0001415889-24-020104.txt : 20240725
0001415889-24-020104.hdr.sgml : 20240725
20240725163133
ACCESSION NUMBER: 0001415889-24-020104
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240723
FILED AS OF DATE: 20240725
DATE AS OF CHANGE: 20240725
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paolini John F.
CENTRAL INDEX KEY: 0001741533
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38492
FILM NUMBER: 241142496
MAIL ADDRESS:
STREET 1: C/O KINIKSA PHARMACEUTICALS, LTD.
STREET 2: CLARENDON HOUSE, 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
FORMER NAME:
FORMER CONFORMED NAME: Paolini John
DATE OF NAME CHANGE: 20180522
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals International, plc
CENTRAL INDEX KEY: 0001730430
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 23 OLD BOND STREET, FLOOR 3
CITY: LONDON
STATE: X0
ZIP: WIS 4PZ
BUSINESS PHONE: 7814319100
MAIL ADDRESS:
STREET 1: 23 OLD BOND STREET, FLOOR 3
CITY: LONDON
STATE: X0
ZIP: WIS 4PZ
FORMER COMPANY:
FORMER CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd.
DATE OF NAME CHANGE: 20180205
4
1
form4-07252024_080729.xml
X0508
4
2024-07-23
0001730430
Kiniksa Pharmaceuticals International, plc
KNSA
0001741533
Paolini John F.
23 OLD BOND STREET, THIRD FLOOR
LONDON
X0
W1S 4PZ
UNITED KINGDOM
false
true
false
false
CHIEF MEDICAL OFFICER
1
Class A Ordinary Share
2024-07-23
4
M
0
22000
1.86
A
69803
D
Class A Ordinary Share
2024-07-23
4
S
0
5530
25.03
D
64273
D
Class A Ordinary Share
2024-07-23
4
S
0
7924
26.36
D
56349
D
Class A Ordinary Share
2024-07-23
4
S
0
8446
27.10
D
47903
D
Class A Ordinary Share
2024-07-23
4
S
0
100
27.87
D
47803
D
Share Option
1.86
2024-07-23
4
M
0
22000
0
D
2026-09-13
Class A Ordinary Share
22000
60217
D
This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.
This transaction was executed in multiple trades through a broker-dealer at prices ranging between $24.63 and $25.62. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging between $25.80 and $26.79. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging between $26.80 and $27.75. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
The option is fully vested and exercisable.
/s/ Madelyn Zeylikman, Attorney-in-Fact
2024-07-25